Temporal arteritis medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
===Pharmacotherapy=== | ===Pharmacotherapy=== | ||
Line 23: | Line 21: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 04:28, 4 February 2013
Temporal Arteritis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Temporal arteritis medical therapy On the Web |
American Roentgen Ray Society Images of Temporal arteritis medical therapy |
Risk calculators and risk factors for Temporal arteritis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Pharmacotherapy
Acute Pharmacotherapies
Prompt treatment with steroids is a medical emergency to reduce the risk of blindness.
Corticosteroids must be started as soon as the diagnosis is suspected (even before the diagnosis is confirmed by biopsy). Steroids do not prevent the diagnosis later being confirmed by biopsy, although certain changes in the histology may be observed towards the end of the first week of treatment and are more difficult to identify after a couple of months.[1]
A 3 day course of pulse steroids with 250 mg of IV solumedrol BID is critical in reducing the risk of permanent visual loss. If there is progression of visual loss on steroids, IV heparin can be administered to reduce the risk of thrombotic occlusion.
Treatment should not be deferred while waiting on the results of a temporal artery biopsy.
References
- ↑ Font RL, Prabhakaran VC (2007). "Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases". The British journal of ophthalmology. 91 (2): 204–9. doi:10.1136/bjo.2006.101725. PMID 16987903.